Biopsy-Proven Fulminant Myocarditis Requiring Mechanical Circulatory Support Following COVID-19 mRNA Vaccination
暂无分享，去创建一个
T. Murohara | T. Okumura | T. Kondo | H. Oishi | T. Kuwayama | H. Hiraiwa | R. Morimoto | T. Saeki | Y. Kimura | S. Kazama | T. Araki | T. Mizutani | Ryota Ito
[1] Mengyun Zhou,et al. Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine , 2022, The American Journal of Cardiology.
[2] I. Jeong,et al. Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation , 2021, Frontiers in Cardiovascular Medicine.
[3] Manfred S. Green,et al. Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel , 2021, The New England journal of medicine.
[4] Chieh-Yu Lin,et al. Myocarditis after Covid-19 mRNA Vaccination , 2021, The New England journal of medicine.
[5] Julie K Boatman,et al. Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients , 2021, International Journal of Cardiology.
[6] P. Hotez,et al. Myocarditis With COVID-19 mRNA Vaccines , 2021, Circulation.
[7] J. Kautzner,et al. Complete recovery of fulminant cytotoxic CD8 T‐cell‐mediated myocarditis after ECMELLA unloading and immunosuppression , 2020, ESC heart failure.
[8] D. Burkhoff,et al. Mode-of-action of the PROPELLA concept in fulminant myocarditis , 2019, European heart journal.